Cone dystrophy

disease
On this page

Also known as progressive cone dystrophystationary cone dystrophy

Summary

Cone dystrophy (MONDO:0000455) is a disease (an umbrella term covering 6 Mondo subtypes) with 31 cohort genes and 4 clinical trials. The dominant Reactome pathway is Inactivation, recovery and regulation of the phototransduction cascade (3 cohort genes).

At a glance

  • Prevalence: Unknown (Worldwide)
  • Umbrella term: 6 Mondo subtypes
  • Cohort genes: 31
  • ClinVar variants: 57
  • Phenotypes (HPO): 5
  • Clinical trials: 4

Clinical features

Signs & symptoms

Clinical features (HPO)

5 HPO clinical features (Orphanet curated; top 5 by frequency):

HPO IDTermFrequency
HP:0000505Visual impairmentVery frequent (80-99%)
HP:0000512Abnormal electroretinogramVery frequent (80-99%)
HP:0000551Color vision defectVery frequent (80-99%)
HP:0000613PhotophobiaVery frequent (80-99%)
HP:0007703Abnormality of retinal pigmentationVery frequent (80-99%)

Identifiers

Disease identifiers

FieldValue
Canonical namecone dystrophy
Mondo IDMONDO:0000455
MeSHD000077765
Orphanet1871
DOIDDOID:0050795
SNOMED CT312917007
UMLSC0730290
MedGen676499
GARD0011897
NORD991
Is cancer (heuristic)no

Also known as: cone dystrophy · progressive cone dystrophy · stationary cone dystrophy

Data availability: 57 ClinVar variants · 7 GenCC gene-disease records.

Disease family

An umbrella term covering 6 Mondo subtypes.

Classification path: disease › human disease › disease by body system or component › nervous system disorderretinal disorderretinal degenerationinherited retinal dystrophyhereditary macular dystrophycone dystrophy

Related subtypes (16): vitelliform macular dystrophy, coloboma of macula, coloboma of macula-brachydactyly type B syndrome, benign concentric annular macular dystrophy, macular dystrophy, fenestrated sheen type, macular coloboma-cleft palate-hallux valgus syndrome, macular corneal dystrophy, EEM syndrome, renal hypomagnesemia 5 with ocular involvement, macular dystrophy, X-linked, AICA-ribosiduria, occult macular dystrophy, familial flecked retinopathy, patterned dystrophy of the retinal pigment epithelium, macular dystrophy, retinal, macular dystrophy with or without cone dysfunction

Subtypes (6): retinal cone dystrophy type 1, cone dystrophy, X-linked, with tapetal-like sheen, cone dystrophy 3, cone dystrophy with supernormal rod response, retinal cone dystrophy 4, cone dystrophy 4

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

57 retrieved; paginated sample, class counts are floors:

20 pathogenic, 14 conflicting classifications of pathogenicity, 11 pathogenic/likely pathogenic, 7 likely pathogenic, 4 uncertain significance, 1 likely benign

ClinVarVariant (HGVS)GeneClassificationReview
634547NM_000350.3(ABCA4):c.5172G>A (p.Trp1724Ter)ABCA4Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
7888NM_000350.3(ABCA4):c.5882G>A (p.Gly1961Glu)ABCA4Pathogenicreviewed by expert panel
813135NM_000350.3(ABCA4):c.3583_3584insGT (p.Leu1195fs)ABCA4Pathogeniccriteria provided, single submitter
813137NM_000350.3(ABCA4):c.4635del (p.Ser1545_Leu1546insTer)ABCA4Pathogeniccriteria provided, single submitter
813147NM_000350.3(ABCA4):c.2588-7_2588-5delinsGGABCA4Pathogeniccriteria provided, single submitter
865769NM_000350.3(ABCA4):c.6005+1G>AABCA4Pathogeniccriteria provided, multiple submitters, no conflicts
99476NM_000350.3(ABCA4):c.6658C>T (p.Gln2220Ter)ABCA4Pathogenicreviewed by expert panel
560424NM_001042472.3(ABHD12):c.447G>A (p.Trp149Ter)ABHD12Pathogenicno assertion criteria provided
438047NM_145200.5(CABP4):c.673C>T (p.Arg225Ter)CABP4Pathogeniccriteria provided, multiple submitters, no conflicts
194793NM_033100.4(CDHR1):c.2522_2528del (p.Ile841fs)CDHR1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
2364NM_201548.5(CERKL):c.769C>T (p.Arg257Ter)CERKLPathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
523393NM_201548.5(CERKL):c.481+2T>GCERKLPathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
428573NM_004928.3(CFAP410):c.218G>C (p.Arg73Pro)CFAP410Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
438156NM_001298.3(CNGA3):c.1405G>A (p.Ala469Thr)CNGA3Pathogeniccriteria provided, single submitter
813040NM_001298.3(CNGA3):c.625T>C (p.Ser209Pro)CNGA3Pathogeniccriteria provided, single submitter
39614NM_201253.3(CRB1):c.2843G>A (p.Cys948Tyr)CRB1Pathogeniccriteria provided, multiple submitters, no conflicts
623278NM_001377295.2(GNAT2):c.620A>T (p.Glu207Val)GNAT2Pathogeniccriteria provided, single submitter
9355NM_000180.4(GUCY2D):c.2512C>T (p.Arg838Cys)GUCY2DPathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
9357NM_000180.4(GUCY2D):c.2513G>A (p.Arg838His)GUCY2DPathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
265419NM_133497.4(KCNV2):c.778A>T (p.Lys260Ter)KCNV2Pathogeniccriteria provided, multiple submitters, no conflicts
813184NM_133497.4(KCNV2):c.1186G>T (p.Gly396Ter)KCNV2Pathogeniccriteria provided, multiple submitters, no conflicts
813186NM_133497.4(KCNV2):c.1356+3_1356+6delKCNV2Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
438390NM_022787.4(NMNAT1):c.271G>A (p.Glu91Lys)NMNAT1Pathogenic/Likely pathogenicno assertion criteria provided
813199NM_031220.4(PITPNM3):c.1657_1660dup (p.Tyr554Ter)PITPNM3Pathogeniccriteria provided, single submitter
13183NM_000322.5(PRPH2):c.424C>T (p.Arg142Trp)PRPH2Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
813080NM_000322.5(PRPH2):c.686_689del (p.Asn229fs)PRPH2Pathogeniccriteria provided, single submitter
9910NM_001034853.2(RPGR):c.3096_3097del (p.Glu1033fs)RPGRPathogeniccriteria provided, multiple submitters, no conflicts
9911NM_001034853.2(RPGR):c.3092_3093del (p.Glu1031fs)RPGRPathogenicreviewed by expert panel
813234NM_020366.4(RPGRIP1):c.2432T>A (p.Leu811His)RPGRIP1Pathogeniccriteria provided, single submitter
96125NM_024592.5(SRD5A3):c.57G>A (p.Trp19Ter)SRD5A3Pathogeniccriteria provided, multiple submitters, no conflicts

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 43 · Orphanet: 67 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

GenCC gene–disease validity (cohort genes)

the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.

GeneClassificationInheritanceDiseaseRecords
GUCA1ADefinitiveAutosomal dominantcone-rod dystrophy 148
PDE6CDefinitiveAutosomal recessivecone dystrophy 46
RP1L1DefinitiveAutosomal dominantoccult macular dystrophy11
IRX5ModerateAutosomal dominantcone dystrophy6
IRX6ModerateAutosomal dominantcone dystrophy
CNGB3SupportiveAutosomal dominantcone dystrophy5
GNAT2SupportiveAutosomal dominantcone dystrophy6

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
GNAT2Orphanet:1871Progressive cone dystrophy
GNAT2Orphanet:49382Achromatopsia
PDE6COrphanet:1871Progressive cone dystrophy
PDE6COrphanet:49382Achromatopsia
IRX5Orphanet:314555Facial dysmorphism-ocular anomalies-osteopenia-intellectual disability-dental anomalies syndrome
RP1L1Orphanet:247834Occult macular dystrophy
RP1L1Orphanet:791Retinitis pigmentosa
CNGB3Orphanet:1871Progressive cone dystrophy
CNGB3Orphanet:49382Achromatopsia
CNGB3Orphanet:827Stargardt disease
GUCA1AOrphanet:1871Progressive cone dystrophy
GUCA1AOrphanet:1872Cone rod dystrophy
GUCA1AOrphanet:75377Central areolar choroidal dystrophy
RPGROrphanet:1872Cone rod dystrophy
RPGROrphanet:244Primary ciliary dyskinesia
RPGROrphanet:247522Primary ciliary dyskinesia-retinitis pigmentosa syndrome
RPGROrphanet:49382Achromatopsia
RPGROrphanet:791Retinitis pigmentosa
SAGOrphanet:75382Oguchi disease
SAGOrphanet:791Retinitis pigmentosa
CFAP410Orphanet:1872Cone rod dystrophy
CFAP410Orphanet:653709Cone rod dystrophy-short stature syndrome
CFAP410Orphanet:803Amyotrophic lateral sclerosis
RPGRIP1Orphanet:1872Cone rod dystrophy
RPGRIP1Orphanet:564Meckel syndrome
RPGRIP1Orphanet:65Leber congenital amaurosis
CABP4Orphanet:714070Incomplete congenital stationary night blindness, Schubert-Bornschein type
CABP4Orphanet:98784Sleep-related hypermotor epilepsy
CDHR1Orphanet:1872Cone rod dystrophy
CDHR1Orphanet:791Retinitis pigmentosa
ABHD12Orphanet:171848Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome
NMNAT1Orphanet:1872Cone rod dystrophy
NMNAT1Orphanet:65Leber congenital amaurosis
WDR19Orphanet:1515Cranioectodermal dysplasia
WDR19Orphanet:3156Senior-Loken syndrome
WDR19Orphanet:474Jeune syndrome
WDR19Orphanet:93592Juvenile nephronophthisis
KCNV2Orphanet:209932Cone dystrophy with supernormal rod response
CACNA2D4Orphanet:1872Cone rod dystrophy
CACNA2D4Orphanet:714070Incomplete congenital stationary night blindness, Schubert-Bornschein type
PITPNM3Orphanet:1872Cone rod dystrophy
CNGA3Orphanet:1872Cone rod dystrophy
CNGA3Orphanet:49382Achromatopsia
CERKLOrphanet:791Retinitis pigmentosa
CRB1Orphanet:251295Pigmented paravenous retinochoroidal atrophy
CRB1Orphanet:35612Nanophthalmos
CRB1Orphanet:65Leber congenital amaurosis
CRB1Orphanet:791Retinitis pigmentosa
SRD5A3Orphanet:324737SRD5A3-CDG
ABCA4Orphanet:1872Cone rod dystrophy

Cohort genes → proteins

31 cohort genes, 31 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence31

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
GNAT2HGNC:4394ENSG00000134183P19087Guanine nucleotide-binding protein G(t) subunit alpha-2gencc,clinvar
PDE6CHGNC:8787ENSG00000095464P51160Cone cGMP-specific 3’,5’-cyclic phosphodiesterase subunit alpha'gencc,clinvar
IRX5HGNC:14361ENSG00000176842P78411Iroquois-class homeodomain protein IRX-5gencc
IRX6HGNC:14675ENSG00000159387P78412Iroquois-class homeodomain protein IRX-6gencc
RP1L1HGNC:15946ENSG00000183638Q8IWN7Retinitis pigmentosa 1-like 1 proteingencc
CNGB3HGNC:2153ENSG00000170289Q9NQW8Cyclic nucleotide-gated channel beta-3gencc
GUCA1AHGNC:4678ENSG00000048545P43080Guanylyl cyclase-activating protein 1gencc
RNF7HGNC:10070ENSG00000114125Q9UBF6RING-box protein 2clinvar
RPGRHGNC:10295ENSG00000156313Q92834X-linked retinitis pigmentosa GTPase regulatorclinvar
SAGHGNC:10521ENSG00000130561P10523S-arrestinclinvar
CFAP410HGNC:1260ENSG00000160226O43822Cilia- and flagella-associated protein 410clinvar
RPGRIP1HGNC:13436ENSG00000092200Q96KN7X-linked retinitis pigmentosa GTPase regulator-interacting protein 1clinvar
CABP4HGNC:1386ENSG00000175544P57796Calcium-binding protein 4clinvar
CDHR1HGNC:14550ENSG00000148600Q96JP9Cadherin-related family member 1clinvar
ABHD12HGNC:15868ENSG00000100997Q8N2K0Lysophosphatidylserine lipase ABHD12clinvar
NMNAT1HGNC:17877ENSG00000173614Q9HAN9Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1clinvar
WDR19HGNC:18340ENSG00000157796Q8NEZ3WD repeat-containing protein 19clinvar
KCNV2HGNC:19698ENSG00000168263Q8TDN2Potassium voltage-gated channel subfamily V member 2clinvar
CACNA2D4HGNC:20202ENSG00000151062Q7Z3S7Voltage-dependent calcium channel subunit alpha-2/delta-4clinvar
PITPNM3HGNC:21043ENSG00000091622Q9BZ71Membrane-associated phosphatidylinositol transfer protein 3clinvar
CNGA3HGNC:2150ENSG00000144191Q16281Cyclic nucleotide-gated channel alpha-3clinvar
CERKLHGNC:21699ENSG00000188452Q49MI3Ceramide kinase-like proteinclinvar
CRB1HGNC:2343ENSG00000134376P82279Protein crumbs homolog 1clinvar
SRD5A3HGNC:25812ENSG00000128039Q9H8P0Polyprenal reductaseclinvar
RGL4HGNC:31911ENSG00000159496Q8IZJ4Ral-GDS-related proteinclinvar
ABCA4HGNC:34ENSG00000198691P78363Retinal-specific phospholipid-transporting ATPase ABCA4clinvar
GUCY2DHGNC:4689ENSG00000132518Q02846Retinal guanylyl cyclase 1clinvar
BBS5HGNC:970ENSG00000163093Q8N3I7BBSome complex member BBS5clinvar
RAB28HGNC:9768ENSG00000157869P51157Ras-related protein Rab-28clinvar
PRPH2HGNC:9942ENSG00000112619P23942Peripherin-2clinvar
RGRHGNC:9990ENSG00000148604P47804RPE-retinal G protein-coupled receptorclinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
GNAT2Guanine nucleotide-binding protein G(t) subunit alpha-2Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems.
PDE6CCone cGMP-specific 3’,5’-cyclic phosphodiesterase subunit alpha'As cone-specific cGMP phosphodiesterase, it plays an essential role in light detection and cone phototransduction by rapidly decreasing intracellular levels of cGMP.
IRX5Iroquois-class homeodomain protein IRX-5Establishes the cardiac repolarization gradient by its repressive actions on the KCND2 potassium-channel gene.
IRX6Iroquois-class homeodomain protein IRX-6Transcription factor.
RP1L1Retinitis pigmentosa 1-like 1 proteinRequired for the differentiation of photoreceptor cells.
CNGB3Cyclic nucleotide-gated channel beta-3Pore-forming subunit of the cone cyclic nucleotide-gated channel.
GUCA1AGuanylyl cyclase-activating protein 1Stimulates retinal guanylyl cyclase when free calcium ions concentration is low and inhibits guanylyl cyclase when free calcium ions concentration is elevated.
RNF7RING-box protein 2Catalytic component of multiple cullin-5-RING E3 ubiquitin-protein ligase complexes (ECS complexes), which mediate the ubiquitination and subsequent proteasomal degradation of target proteins.
RPGRX-linked retinitis pigmentosa GTPase regulatorActs as a guanine-nucleotide releasing factor (GEF) for RAB8A and RAB37 by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP.
SAGS-arrestinBinds to photoactivated, phosphorylated RHO and terminates RHO signaling via G-proteins by competing with G-proteins for the same binding site on RHO.
CFAP410Cilia- and flagella-associated protein 410Plays a role in cilia formation and/or maintenance.
RPGRIP1X-linked retinitis pigmentosa GTPase regulator-interacting protein 1May function as scaffolding protein.
CABP4Calcium-binding protein 4Involved in normal synaptic function through regulation of Ca(2+) influx and neurotransmitter release in photoreceptor synaptic terminals and in auditory transmission.
CDHR1Cadherin-related family member 1Potential calcium-dependent cell-adhesion protein.
ABHD12Lysophosphatidylserine lipase ABHD12Lysophosphatidylserine (LPS) lipase that mediates the hydrolysis of lysophosphatidylserine, a class of signaling lipids that regulates immunological and neurological processes.
NMNAT1Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1Catalyzes the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP.
WDR19WD repeat-containing protein 19As component of the IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs), it is involved in cilia function and/or assembly.
KCNV2Potassium voltage-gated channel subfamily V member 2Potassium channel subunit.
CACNA2D4Voltage-dependent calcium channel subunit alpha-2/delta-4The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel.
PITPNM3Membrane-associated phosphatidylinositol transfer protein 3Catalyzes the transfer of phosphatidylinositol and phosphatidylcholine between membranes (in vitro).
CNGA3Cyclic nucleotide-gated channel alpha-3Pore-forming subunit of the cone cyclic nucleotide-gated channel.
CERKLCeramide kinase-like proteinHas no detectable ceramide-kinase activity.
CRB1Protein crumbs homolog 1Plays a role in photoreceptor morphogenesis in the retina.
SRD5A3Polyprenal reductasePlays a key role in early steps of protein N-linked glycosylation by being involved in the conversion of polyprenol into dolichol.
ABCA4Retinal-specific phospholipid-transporting ATPase ABCA4Flippase that catalyzes in an ATP-dependent manner the transport of retinal-phosphatidylethanolamine conjugates like 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine (N-Ret-PE) from the lumen to the cytoplasmic leafl…
GUCY2DRetinal guanylyl cyclase 1Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors.
BBS5BBSome complex member BBS5The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia.
RAB28Ras-related protein Rab-28The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes.
PRPH2Peripherin-2Essential for retina photoreceptor outer segment disk morphogenesis, may also play a role with ROM1 in the maintenance of outer segment disk structure.
RGRRPE-retinal G protein-coupled receptorReceptor for all-trans- and 11-cis-retinal.

Protein-family classification

Druggable: 9 · Difficult: 5 · Unknown: 17 · Druggable fraction: 0.29

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Ion channel310.8×0.019
Transporter12.5×0.579
Kinase21.8×0.579
Transcription factor51.3×0.579
Other/Unknown171.0×0.743
Enzyme (other)20.8×0.743
GPCR10.8×0.743

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
GNAT2Other/UnknownnoGprotein_alpha_su, Gprotein_alpha_I, GproteinA_insert
PDE6CTranscription factornoPDEase_catalytic_dom, GAF, HD/PDEase_dom
IRX5Transcription factornoHD, Iroquois_homeo, KN_HD
IRX6Transcription factornoHD, Iroquois_homeo, KN_HD
RP1L1Other/UnknownnoDoublecortin_dom, Doublecortin_dom_sf
CNGB3Ion channelyescNMP-bd_dom, Ion_trans_dom, RmlC-like_jellyroll
GUCA1AOther/UnknownnoEF_hand_dom, EF-hand-dom_pair, EF_Hand_1_Ca_BS
RNF7Transcription factornoZnf_RING, Znf_RING/FYVE/PHD, Znf_RING_H2
RPGROther/UnknownnoReg_chr_condens, RCC1/BLIP-II, Signaling_Regulatory_Domain
SAGOther/UnknownnoArrestin, Arrestin-like_N, Arrestin-like_C
CFAP410Other/UnknownnoLeu-rich_rpt, U2A’_phosphoprotein32A_C, LRR_dom_sf
RPGRIP1Other/UnknownnoC2_dom, C2-C2_1, RPGRIP1_fam
CABP4Other/UnknownnoEF_hand_dom, EF-hand-dom_pair, EF_Hand_1_Ca_BS
CDHR1Other/UnknownnoCadherin-like_dom, Cadherin-like_sf, Cadherin_CS
ABHD12Other/UnknownnoAB_hydrolase_1, AB_hydrolase_fold
NMNAT1Enzyme (other)yes2.7.7.1Cyt_trans-like, NadD/NMNAT, Rossmann-like_a/b/a_fold
WDR19Transcription factornoWD40_rpt, TPR-like_helical_dom_sf, WD40/YVTN_repeat-like_dom_sf
KCNV2Ion channelyesT1-type_BTB, K_chnl_volt-dep_Kv, K_chnl_volt-dep_Kv5/Kv9
CACNA2D4Other/UnknownnoVWF_A, VWA_N, VDCC_a2/dsu
PITPNM3Other/UnknownnoPI_transfer, DDHD_dom, HAD_sf
CNGA3Ion channelyescNMP-bd_dom, Ion_trans_dom, RmlC-like_jellyroll
CERKLKinaseyesDiacylglycerol_kinase_cat_dom, NAD/diacylglycerol_kinase_sf, ATP-NAD_kinase_N
CRB1Other/UnknownnoEGF-type_Asp/Asn_hydroxyl_site, EGF, Laminin_G
SRD5A3Enzyme (other)yes1.3.1.223-oxo-5_a-steroid_4-DH_C, Dfg10/SRD5A3
RGL4Other/UnknownnoRASGEF_cat_dom, Ras-like_GEF, Ras_GEF_dom_sf
ABCA4TransporteryesABC_transporter-like_ATP-bd, AAA+_ATPase, ABCA4/ABCR
GUCY2DKinaseyes4.6.1.2Prot_kinase_dom, A/G_cyclase, Ser-Thr/Tyr_kinase_cat_dom
BBS5Other/UnknownnoBBL5, PH-like_dom_sf, BBS5_PH
RAB28Other/UnknownnoSmall_GTPase, Small_GTP-bd, P-loop_NTPase
PRPH2Other/UnknownnoPeripherin/rom-1, Tetraspanin_EC2_sf, Peripherin/rom-1_CS
RGRGPCRyesGPCR_Rhodpsn, RPE_GPCR, GPCR_Rhodpsn_7TM

Expression context

Cohort genes with no expression data: 0.

28 cohort genes are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)31
unknown0

Top tissues across cohort

TissueCohort genes
male germ line stem cell (sensu Vertebrata) in testis7
primordial germ cell in gonad4
right uterine tube4
bronchial epithelial cell3
skin of abdomen3
hindlimb stylopod muscle3
pigmented layer of retina3
sperm3
endothelial cell3
olfactory segment of nasal mucosa3
secondary oocyte2
bone marrow cell2
buccal mucosa cell2
nucleus accumbens2
left testis2
adenohypophysis2
ganglionic eminence2
ventricular zone2
oocyte1
cerebellar hemisphere1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
GNAT2153tissue_specificmarkeroocyte, primordial germ cell in gonad, secondary oocyte
PDE6C159tissue_specificmarkersecondary oocyte, male germ line stem cell (sensu Vertebrata) in testis, cerebellar hemisphere
IRX5163broadmarkerupper leg skin, bronchial epithelial cell, skin of abdomen
IRX695tissue_specificmarkerapex of heart, skin of abdomen, hindlimb stylopod muscle
RP1L130tissue_specificyesprimordial germ cell in gonad, buccal mucosa cell, bone marrow cell
CNGB3161tissue_specificmarkermale germ line stem cell (sensu Vertebrata) in testis, pigmented layer of retina, diaphragm
GUCA1A52broadmarkernucleus accumbens, putamen, hypothalamus
RNF7292ubiquitousmarkerleft adrenal gland, left adrenal gland cortex, right adrenal gland
RPGR281ubiquitousmarkersperm, bronchial epithelial cell, right uterine tube
SAG106tissue_specificmarkernucleus accumbens, male germ line stem cell (sensu Vertebrata) in testis, left testis
CFAP410190ubiquitousmarkerright uterine tube, adenohypophysis, right frontal lobe
RPGRIP1168tissue_specificmarkerleft testis, sperm, right testis
CABP4226broadmarkervena cava, cardia of stomach, ventral tegmental area
CDHR1186broadmarkerupper arm skin, skin of leg, skin of abdomen
ABHD12256ubiquitousmarkerC1 segment of cervical spinal cord, prefrontal cortex, spinal cord
NMNAT1225ubiquitousyeshindlimb stylopod muscle, muscle of leg, mucosa of transverse colon
WDR19269ubiquitousmarkerright uterine tube, bronchial epithelial cell, adenohypophysis
KCNV261tissue_specificmarkersperm, male germ cell, primordial germ cell in gonad
CACNA2D4136broadyesmonocyte, leukocyte, granulocyte
PITPNM3222broadmarkerpancreatic ductal cell, endothelial cell, Brodmann (1909) area 23
CNGA3110tissue_specificmarkerventricular zone, male germ line stem cell (sensu Vertebrata) in testis, ganglionic eminence
CERKL122tissue_specificmarkerislet of Langerhans, olfactory segment of nasal mucosa, male germ line stem cell (sensu Vertebrata) in testis
CRB1163broadmarkerganglionic eminence, ventricular zone, endothelial cell
SRD5A3254ubiquitousmarkerpalpebral conjunctiva, gall bladder, olfactory segment of nasal mucosa
RGL4155broadmarkerbone marrow, bone marrow cell, blood
ABCA4164tissue_specificmarkerpigmented layer of retina, primordial germ cell in gonad, male germ line stem cell (sensu Vertebrata) in testis
GUCY2D121tissue_specificmarkerbuccal mucosa cell, esophagus mucosa, lower esophagus mucosa
BBS5140ubiquitousmarkerright uterine tube, male germ line stem cell (sensu Vertebrata) in testis, olfactory segment of nasal mucosa
RAB28284ubiquitousmarkertibia, germinal epithelium of ovary, endothelial cell
PRPH2176tissue_specificmarkerquadriceps femoris, vastus lateralis, hindlimb stylopod muscle

Protein interactions among cohort

Intra-cohort edges: 54.

Hub genes (top 10 by interactor count)

SymbolInteractor count
RNF72,453
NMNAT12,424
RPGR2,231
SAG1,927
KCNV21,908
CABP41,897
GNAT21,675
RAB281,563
IRX61,533
ABCA41,532

Intra-cohort edges

ABSources
ABCA4CDHR1string_interaction
ABCA4CERKLstring_interaction
ABCA4CNGB3string_interaction
ABCA4GUCY2Dstring_interaction
ABCA4KCNV2string_interaction
ABCA4PITPNM3string_interaction
ABCA4PRPH2string_interaction
ABCA4RGRstring_interaction
ABCA4RP1L1string_interaction
ABCA4RPGRstring_interaction
CABP4CACNA2D4string_interaction
CACNA2D4KCNV2string_interaction
CDHR1CERKLstring_interaction
CDHR1GUCY2Dstring_interaction
CDHR1KCNV2string_interaction
CDHR1PITPNM3string_interaction
CDHR1PRPH2string_interaction
CDHR1RAB28string_interaction
CDHR1RPGRIP1string_interaction
CERKLRGRstring_interaction
CERKLRP1L1string_interaction
CERKLRPGRstring_interaction
CNGA3CNGB3biogrid_interaction, string_interaction
CNGA3GNAT2string_interaction
CNGA3GUCY2Dstring_interaction
CNGA3KCNV2string_interaction
CNGA3PDE6Cstring_interaction
CNGA3RPGRstring_interaction
CNGB3GNAT2string_interaction
CNGB3GUCY2Dstring_interaction
CNGB3KCNV2string_interaction
CNGB3PDE6Cstring_interaction
CNGB3RPGRstring_interaction
CNGB3RPGRIP1string_interaction
GNAT2PDE6Cstring_interaction
GUCA1AGUCY2Dstring_interaction
GUCA1ARPGRIP1string_interaction
GUCY2DKCNV2string_interaction
GUCY2DNMNAT1string_interaction
GUCY2DPDE6Cstring_interaction
GUCY2DPITPNM3string_interaction
GUCY2DPRPH2string_interaction
GUCY2DRPGRIP1string_interaction
IRX5IRX6string_interaction
KCNV2PDE6Cstring_interaction
KCNV2RPGRIP1string_interaction
PITPNM3RAB28string_interaction
PITPNM3RPGRIP1string_interaction
PRPH2RP1L1string_interaction
PRPH2RPGRstring_interaction

Structural data

PDB: 16 · AlphaFold-only: 15 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
CNGA3Q1628110
CNGB3Q9NQW89
ABCA4P783638
PDE6CP511607
RNF7Q9UBF67
NMNAT1Q9HAN96
WDR19Q8NEZ34
RPGRQ928343
GNAT2P190872
RAB28P511572
CFAP410O438221
RPGRIP1Q96KN71
PITPNM3Q9BZ711
CRB1P822791
BBS5Q8N3I71
PRPH2P239421

AlphaFold-only cohort genes (top 30 by pLDDT)

SymbolUniProtpLDDT
RGRP4780490.04
SRD5A3Q9H8P089.07
ABHD12Q8N2K085.60
SAGP1052385.44
GUCY2DQ0284682.37
CACNA2D4Q7Z3S781.69
CERKLQ49MI379.82
CDHR1Q96JP978.79
KCNV2Q8TDN275.55
GUCA1AP4308071.28
CABP4P5779665.01
RGL4Q8IZJ462.88
IRX6P7841255.29
IRX5P7841155.14
RP1L1Q8IWN738.97

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 53. Enrichment computed across 31 evidence-associated genes (14 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 14 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
Inactivation, recovery and regulation of the phototransduction cascade368.0×5e-04SAG, GUCA1A, GUCY2D
Defective SRD5A3 causes SRD5A3-CDG, KHRZ1815.7×0.017SRD5A3
Defective visual phototransduction due to ABCA4 loss of function1815.7×0.017ABCA4
Visual phototransduction237.1×0.017SAG, ABCA4
Diseases associated with glycosylation precursor biosynthesis1407.9×0.026SRD5A3
Retinoid cycle disease events1203.9×0.032ABCA4
Diseases associated with visual transduction1203.9×0.032ABCA4
Diseases of the neuronal system1203.9×0.032ABCA4
Synthesis of PI1163.1×0.032PITPNM3
Arachidonate production from DAG1163.1×0.032ABHD12
Synthesis of dolichyl-phosphate1116.5×0.041SRD5A3
Sensory Perception213.6×0.041SAG, ABCA4
The phototransduction cascade190.6×0.042SAG
Opsins190.6×0.042RGR
Androgen biosynthesis174.2×0.047SRD5A3
Activation of the phototransduction cascade168.0×0.048SAG
Metabolism of steroid hormones137.1×0.078SRD5A3
The canonical retinoid cycle in rods (twilight vision)137.1×0.078ABCA4
BBSome-mediated cargo-targeting to cilium135.5×0.078BBS5
Effects of PIP2 hydrolysis132.6×0.079ABHD12
Inactivation of CSF3 (G-CSF) signaling131.4×0.079RNF7
Nicotinate metabolism128.1×0.084NMNAT1
Synthesis of substrates in N-glycan biosythesis120.9×0.108SRD5A3
G alpha (i) signalling events25.6×0.108GNAT2, RGR
Cargo trafficking to the periciliary membrane117.7×0.114BBS5
Voltage gated Potassium channels117.4×0.114KCNV2
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein114.8×0.128SRD5A3
Intraflagellar transport114.3×0.128WDR19
Ca2+ pathway112.8×0.134GNAT2
Hedgehog ‘off’ state112.8×0.134WDR19

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 31 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
visual perception1538.5×8e-19GNAT2, PDE6C, RPGR, RPGRIP1, CABP4, IRX5, RP1L1, CNGA3 (+7 more)
photoreceptor cell outer segment organization4135.9×1e-06CDHR1, RP1L1, CRB1, PRPH2
detection of light stimulus involved in visual perception483.6×7e-06GNAT2, CACNA2D4, CRB1, PRPH2
phototransduction464.0×2e-05GNAT2, CABP4, GUCA1A, RGR
retinal cone cell development3135.9×4e-05GNAT2, PDE6C, CABP4
photoreceptor cell maintenance446.3×4e-05CDHR1, RP1L1, CRB1, ABCA4
photoreceptor cell morphogenesis2181.2×1e-03CABP4, CDHR1
retinal bipolar neuron differentiation2181.2×1e-03CABP4, IRX5
phototransduction, visible light283.6×0.004PDE6C, ABCA4
retina development in camera-type eye324.7×0.004RP1L1, CNGA3, PRPH2
gonad development272.5×0.005IRX5, WDR19
cellular response to light stimulus268.0×0.005CRB1, RGR
cell development257.2×0.007IRX5, IRX6
monoatomic cation transport249.4×0.008CNGA3, CNGB3
cilium assembly49.5×0.008RPGR, CFAP410, WDR19, BBS5
monoatomic cation transmembrane transport240.3×0.011CNGA3, CNGB3
embryonic cranial skeleton morphogenesis237.5×0.012IRX5, WDR19
response to low light intensity stimulus1543.6×0.014PRPH2
polyprenol catabolic process1543.6×0.014SRD5A3
positive regulation of guanylate cyclase activity1543.6×0.014GUCA1A
camera-type eye photoreceptor cell development1543.6×0.014CRB1
post-embryonic retina morphogenesis in camera-type eye1271.8×0.024CRB1
inorganic cation import across plasma membrane1271.8×0.024CNGA3
background adaptation1271.8×0.024GNAT2
phospholipid transfer to membrane1181.2×0.031ABCA4
homeostasis of number of retina cells1181.2×0.031GNAT2
establishment of bipolar cell polarity involved in cell morphogenesis1181.2×0.031CRB1
phosphatidylserine catabolic process1135.9×0.031ABHD12
photoreceptor cell development1135.9×0.031RP1L1
ear morphogenesis1135.9×0.031WDR19

Therapeutics

Drug target analysis

Approved (phase 4): 3 · Phase ≥3: 3 · Phased (≥1): 3 · Undrugged: 28

Druggability breadth: 7 of 31 evidence-associated genes (23%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Genes with an approved drug

The molecule shown is one approved compound that hits the gene — not necessarily a drug of choice or one indicated for this disease.

SymbolExample approved molecule
PDE6CVARDENAFIL
ABHD12ORLISTAT
CACNA2D4NIMODIPINE

Top cohort targets by molecule count

SymbolMoleculesMax phase
PDE6C64
ABHD1224
CACNA2D424
GNAT200
IRX500
IRX600
RP1L100
CNGB300
GUCA1A00
RNF700

Drugs targeting cohort genes (top 30)

MoleculeMax phaseTargets in cohort
VARDENAFIL4PDE6C
SILDENAFIL4PDE6C
TADALAFIL4PDE6C
DIPYRIDAMOLE4PDE6C
ORLISTAT4ABHD12
DRONABINOL4ABHD12
NIMODIPINE4CACNA2D4
TACRINE4CACNA2D4
ZAPRINAST2PDE6C
TBA-73712PDE6C

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 3.

Cohort genes with ChEMBL bioactivity (full, sorted by assay count)

SymbolAssaysType breakdown
PDE6C103Binding:97, ADMET:6
ABHD1235Binding:31, Toxicity:3, ADMET:1
KCNV221Binding:20, Toxicity:1
CACNA2D413Binding:13
NMNAT13Binding:3
CFAP4101Binding:1
SRD5A31Binding:1

Cohort enzymes (BRENDA EC)

SymbolEC numbersNames
NMNAT12.7.7.1, 2.7.7.18nicotinamide-nucleotide adenylyltransferase, nicotinate-nucleotide adenylyltransferase
SRD5A31.3.1.22, 1.3.1.94, 1.3.1.B133-oxo-5alpha-steroid 4-dehydrogenase (NADP+), polyprenal reductase,
GUCY2D4.6.1.2guanylate cyclase

Cohort genes with high screening signal

≥100 ChEMBL assays — a studied-ness signal; see Therapeutics for approved-drug status.

SymbolChEMBL assays
PDE6C103

Pharmacogenomics

Cohort genes with a PharmGKB record: 31; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

10 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

CompoundMax phaseCohort target (bioactivity)
VARDENAFIL4PDE6C
SILDENAFIL4PDE6C
TADALAFIL4PDE6C
DIPYRIDAMOLE4PDE6C
ORLISTAT4ABHD12
DRONABINOL4ABHD12
NIMODIPINE4CACNA2D4
TACRINE4CACNA2D4
ZAPRINAST2PDE6C
TBA-73712PDE6C

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)3PDE6C, ABHD12, CACNA2D4
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug4CNGB3, NMNAT1, CNGA3, ABCA4
DDruggable family + AlphaFold only, no drug5KCNV2, CERKL, SRD5A3, GUCY2D, RGR
EDifficult family or no structure, no drug19GNAT2, IRX5, IRX6, RP1L1, GUCA1A, RNF7, RPGR, SAG, CFAP410, RPGRIP1 (+9 more)

Undrugged target profiles

28 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
GNAT20PDE6C
CNGB30PDE6C
CNGA30PDE6C
IRX50
IRX60
RP1L10
GUCA1A0
RNF70
RPGR0
SAG0
CFAP4101
RPGRIP10
CABP40
CDHR10
NMNAT13
WDR190
KCNV221
PITPNM30
CERKL0
CRB10
SRD5A31
RGL40
ABCA40
GUCY2D0
BBS50
RAB280
PRPH20
RGR0

Clinical trials & evidence

Clinical trials

Clinical trials: 4.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified4

Top trials by phase / activity

NCTPhaseStatusTitle
NCT02435940Not specifiedRECRUITINGInherited Retinal Degenerative Disease Registry
NCT05355415Not specifiedRECRUITINGAdaptive Optics Imaging of Outer Retinal Diseases
NCT03990727Not specifiedUNKNOWNPhenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.
NCT04658251Not specifiedTERMINATEDStudy of New Mutations in Cone Disorders